Johns Hopkins Oncology Center Bunting Blaustein Building

Baltimore, Maryland 21231

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin

Studies at this site

• Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) — Completed